Table 1.
Summary of model parameters and clinical information for all nine patients with glioblastoma multiforme included in the study. Survival is calculated in months, relative to the first MRI observation.
| Patient | Age | EOR | T1Gd Velocity (mm/year) | T2 velocity (mm/year) | D (mm2/year) | ρ (/year) | α T1Gd (/Gy) | αT2 (/Gy) | Survival from 1st MRI observation (months) | Concurrent Chemo |
|---|---|---|---|---|---|---|---|---|---|---|
| 1* | 63 | BX | 50.9 | 32.1 | 18.43 | 35.13 | 0.244 | 0.162 | 88.0 | TMZ |
| 2* | 43 | BX | 195.4 | 0.0 | 7.52 | 12.68 | 0.085 | 0.137 | 24.3 | TMZ |
| 3 | 53 | BX | 85.3 | 19.9 | 27.70 | 3.59 | 0.000 | 0.005 | 34.3 | - |
| 4 | 63 | BX | 83.8 | 21.9 | 7.88 | 15.24 | 0.004 | 0.000 | 13.2 | TMZ |
| 5 | 49 | STR | 42.3 | 66.9 | 8.90 | 50.29 | 0.222 | 0.265 | 18.8 | BCNU + TMZ |
| 6* | 73 | BX | 24.3 | −61.6 | 10.82 | 13.68 | 0.023 | 0.076 | 40.3 | TMZ |
| 7 | 56 | BX | 53.1 | 11.2 | 50.71 | 13.88 | 0.016 | 0.028 | 12.8 | TMZ |
| 8 | 63 | BX | 20.1 | 44.1 | 12.64 | 7.99 | 0.016 | 0.032 | 15.6 | TMZ |
| 9 | 45 | STR | 1.9 | 21.1 | 6.56 | 17.04 | 0.115 | 0.084 | 21.3 | TMZ |
*
indicates patient is still alive